Extravasation of Antineoplastic Agents: Prevention And Treatments

Boschi, Rita; Rostagno, Elena

doi:10.4081/pr.2012.e28

Pediatric Reports is published by MDPI from Volume 12 Issue 3 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.

Review

1 August 2012

3 Pages

Extravasation of Antineoplastic Agents: Prevention And Treatments

and

IOR, via G.C.Pupilli n. 1-40136 Bologna, Italy

Ospedale Sant’Orsola Malpighi, Bologna, Italy

Author to whom correspondence should be addressed.

Pediatr. Rep.2012, 4(3), e28;https://doi.org/10.4081/pr.2012.e28

Version Notes

Order Reprints

Abstract

The extravasation of antineoplastic agents is an unwanted and distressing situation that can easily occur. It may cause severe and irreversible local injuries. Left untreated, vesicant chemotherapy extravasation can potentially cause tissue necrosis, functional impairment and permanent disfigurement. This article provides a review of current literature regarding recommendations on the prevention and treatment of extravasation of antineoplastic agents.

Keywords:

antineoplastic agents; extravasion; pediatrics

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Treatment of Foodborne Botulism in Current Clinical Toxicology: Authors’ Reply

A Case of Shwachman-Diamond Syndrome Distinguished from Celiac Disease